News
Emmace Awarded Additional FDA Research Project Along with University of Florida
Emmace Consulting will participate in yet another project (Grant #75F40119C10154) sponsored by US Food and Drug Administration (FDA). The company will use its methods and models to conduct studies that may challenge current pharmacopeia [...]
Emmace Consulting chosen to work in collaboration with UF on FDA Project
Emmace Consulting, a Swedish Company, was awarded a sub-contract by the University of Florida after they were awarded the U01FD004943 Grant by the FDA. Emmace Consulting, internationally recognized for its expertise in inhalation studies, [...]
Emmace is attending RDD 2019 Europe in Lisbon
Mårten Svensson, CEO of Emmace Consulting is attending RDD 2019 in Portugal and will be happy to discuss how Emmace Consulting can help you develop inhaled products.
Emmace has Graduated!
Now a proud SmiLe Alumni member! https://www.linkedin.com/feed/update/urn:li:activity:6495303115359817728
Emmace Consulting at DDL2018
Emmace will have a strong presence during the upcoming DDL2018 conference. Please drop by and have a chat with our advisors and specialists. Emmace Consulting is a Bronze Sponsor (booth 314) at Drug Delivery [...]
Per Bäckman has joined Emmace Consulting
Per Bäckman, Senior Inhalation Consultant, now in our team. #amazingstaff 😉 Read more about Emmace Team
Emmace Consulting is attending RDD 2018 Arizona
Emmace Consulting is attending RDD 2018 in Arizona as a technology exhibitor. Both Bo Olsson and Mårten Svensson will be happy to discuss how Emmace Consulting can help you develop inhaled products. Two posters [...]
F2F demo of Mimetikos Preludium™ at DDL2017
During the upcoming DDL2017 conference, Dr. Bo Olsson, Senior Advisor at Emmace Consulting, will be happy to demonstrate the Mimetikos Preludium application for anyone interested. Book a F2F meeting with Bo by contacting him [...]
Now published: A novel, more in-vivo realistic, characterization approach for nebulizers
Emmace Consulting has, in collaboration with S5 Consulting and Jolyon Mitchell Inhaler Consulting Services Inc, jointly published an analytical test approach that is more in-vivo like than the existing pharmacopeia methods. Don’t hesitate to [...]
Joint Research Agreement between Emmace Consulting AB, Mylan Pharma UK LtD and the University of Cyprus
In May 2017, the University of Cyprus (Cyprus), Mylan Pharma UK Ltd (UK), and Emmace Consulting AB entered into a joint research agreement with the aim of developing a state-of-the-art scientific methodology to study [...]
Emmace Consulting releases Mimetikos Preludium™
Emmace Consulting is proud to present the release of Mimetikos Preludium™, a software for estimating regional deposition of inhaled aerosols in man. Mimetikos Preludium™ software is a modeling package for estimating regional deposition of [...]
Dissolution Testing of Medicated Chewing Gums – a New Analytical Service
Emmace Consulting AB offers dissolution testing of medicated chewing gums as an analytical service to clients on a CRO basis. The testing is performed according to Eur. Pharmacopoeia 2.9.25, using Apparatus B. Read more [...]